Bryan Ridgell is a seasoned professional with over 20 years of experience in project and portfolio management within the biotech and pharmaceutical sectors. Currently serving as the Senior Vice President at Geron Corporation, Bryan excels in leading cross-functional teams and overseeing strategic planning for oncology and hematology asset portfolios. Previously, at GlycoMimetics, Inc., Bryan successfully directed multi-scenario strategic initiatives following a pivotal Phase 3 trial, driving organizational transformation from research to commercialization. Bryan holds an MBA from The Johns Hopkins University and a Bachelor's degree in Environmental Chemistry from the Florida Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices